ADC Therapeutics's market cap is currently $400.50M. The company's EPS TTM is $-0.5; its P/E ratio is ―; ADC Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
